Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
A cardiac surgery and heart failure team at the University of Michigan implanted a novel mechanical heart pump into a ...
Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of a ...
Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of ...
Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be ...
Researchers have long known that patients who leave emergency departments before medically advised use more emergency care services, are more ...
Increased use of ventilation and air cleaners, designed to mitigate the spread of viral infections in hospitals, is likely to ...
A new research paper was published in Oncotarget's Volume 16 on January 21, 2025, titled "Assessment of cfDNA release dynamics during colorectal cancer ...
In patients undergoing coronary artery bypass grafting (CABG), a novel analysis evaluating surgeon preference for multi- versus single-arterial grafting may ...
AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net